Understanding the Role of Mutations in SF3B1 and Splicing in Chronic Lymphocytic Leukemia

被引：0
|
作者：
Wu, Catherine J. [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
15
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The role of SF3B1 and NOTCH1 in the pathogenesis of leukemia
    Abolhasani, Shiva
    Hejazian, Seyyed Sina
    Karpisheh, Vahid
    Khodakarami, Atefeh
    Mohammadi, Hamed
    Navashenaq, Jamshid Gholizadeh
    Hojjat-Farsangi, Mohammad
    Jadidi-Niaragh, Farhad
    IUBMB LIFE, 2023, 75 (03) : 257 - 278
  • [42] INTEGRATED B-CELL RECEPTOR-INDUCED ERK SIGNALING AND SF3B1 GENE MUTATIONS REFINE PROGNOSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Cavallini, C.
    Putta, S.
    Visco, C.
    Purvis, N.
    Rossi, D.
    Mimiola, E.
    Perbellini, O.
    Lovato, O.
    Falisi, E.
    Facco, M.
    Trentin, L.
    Gaidano, G.
    Semenzato, G.
    Ambrosetti, A.
    Pizzolo, G.
    Cesano, A.
    Scupoli, M. T.
    HAEMATOLOGICA, 2016, 101 : S108 - S109
  • [43] SF3B1 Mutations in Hematological Malignancies
    Cilloni, Daniela
    Itri, Federico
    Bonuomo, Valentina
    Petiti, Jessica
    CANCERS, 2022, 14 (19)
  • [44] Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma
    Harbour, J. William
    Roberson, Elisha D. O.
    Anbunathan, Hima
    Onken, Michael D.
    Worley, Lori A.
    Bowcock, Anne M.
    NATURE GENETICS, 2013, 45 (02) : 133 - 135
  • [45] Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma
    J William Harbour
    Elisha D O Roberson
    Hima Anbunathan
    Michael D Onken
    Lori A Worley
    Anne M Bowcock
    Nature Genetics, 2013, 45 : 133 - 135
  • [46] Role Of Sf3b1 On Hematopoiesis
    Matsunawa, Manabu
    Yamamoto, Ryo
    Sanada, Masashi
    Sato, Aiko
    Shiozawa, Yusuke
    Yoshida, Kenichi
    Nagata, Yasunobu
    Kon, Ayana
    Yoshizato, Tetsuichi
    Otsu, Makoto
    Isono, Kyoichi
    Koseki, Haruhiko
    Nakauchi, Hiromitsu
    Ogawa, Seishi
    BLOOD, 2013, 122 (21)
  • [47] Perspectives on Precision Medicine in Chronic Lymphocytic Leukemia: Targeting Recurrent Mutations-NOTCH1, SF3B1, MYD88, BIRC3
    Putowski, Maciej
    Giannopoulos, Krzysztof
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (16)
  • [48] Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia
    Nadeu, Ferran
    Delgado, Julio
    Royo, Cristina
    Baumann, Tycho
    Stankovic, Tatjana
    Pinyol, Magda
    Jares, Pedro
    Navarro, Alba
    Martin-Garcia, David
    Bea, Silvia
    Salaverria, Itziar
    Oldreive, Ceri
    Aymerich, Marta
    Suarez-Cisneros, Helena
    Rozman, Maria
    Villamor, Neus
    Colomer, Dolors
    Lopez-Guillermo, Armando
    Gonzalez, Marcos
    Alcoceba, Miguel
    Jose Terol, Maria
    Colado, Enrique
    Puente, Xose S.
    Lopez-Otin, Carlos
    Enjuanes, Anna
    Campo, Elias
    BLOOD, 2016, 127 (17) : 2122 - 2130
  • [49] Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2
    Strefford, J. C.
    Sutton, L-A
    Baliakas, P.
    Agathangelidis, A.
    Malcikova, J.
    Plevova, K.
    Scarfo, L.
    Davis, Z.
    Stalika, E.
    Cortese, D.
    Cahill, N.
    Pedersen, L. B.
    di Celle, P. F.
    Tzenou, T.
    Geisler, C.
    Panagiotidis, P.
    Langerak, A. W.
    Chiorazzi, N.
    Pospisilova, S.
    Oscier, D.
    Davi, F.
    Belessi, C.
    Mansouri, L.
    Ghia, P.
    Stamatopoulos, K.
    Rosenquist, R.
    LEUKEMIA, 2013, 27 (11) : 2196 - 2199
  • [50] Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization
    Liu, Zhaoqi
    Yoshimi, Akihide
    Wang, Jiguang
    Cho, Hana
    Lee, Stanley Chun-Wei
    Ki, Michelle
    Bitner, Lillian
    Chu, Timothy
    Shah, Harshal
    Liu, Bo
    Mato, Anthony R.
    Ruvolo, Peter
    Fabbri, Giulia
    Pasqualucci, Laura
    Abdel-Wahab, Omar
    Rabadan, Raul
    CANCER DISCOVERY, 2020, 10 (06) : 806 - 821
12345